If you're thinking about getting a Covid booster shot, you're probably wondering about its side effects. Don't worry: Compared with your last dose, your booster shot should be a much smoother ...

Pfizer's COVID-19 booster shot yields mild to moderate side effects, much like its second dose. Injection-site pain is the most common, as well as headaches and fatigue. See more stories on Insider's ...

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study. The research, led by Murdoch ...

In a recent study published in The Lancet Regional Health Western Pacific, researchers compare the immunogenicity, reactogenicity, and safety of a half-dose Pfizer-BioNTech BNT162b2 coronavirus ...

Side effects from COVID-19 booster shots generally resemble those after a second dose. Fatigue, headaches, and muscle aches are common after both. But two shots of J&J's vaccine yield fewer side ...

Respiratory virus season is coming up fast and, with that, there’s a big emphasis on getting up to date with vaccines to protect yourself in the months ahead. One that’s getting a lot of buzz in ...

Add Yahoo as a preferred source to see more of our stories on Google. Do I need the new COVID booster? Eligibility, side effects, cost and more As the United States enters the thick of respiratory ...

If you're thinking of getting an omicron-specific Covid booster shot, you might be wondering what its side effects are — and how severe they might be. Rest assured: They're not expected to be much ...

Side effects after receiving a COVID-19 booster shot appear similar to those after receiving a second dose of the vaccine, described as "mild to moderate," according to the U.S. Centers for Disease ...

Add Yahoo as a preferred source to see more of our stories on Google. (NEXSTAR) — The Centers for Disease Control and Prevention have approved new COVID-19 vaccines for nearly all Americans as ...

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least two ...